Cargando…

Familial Occurrence of Systemic Mast Cell Activation Disease

Systemic mast cell activation disease (MCAD) comprises disorders characterized by an enhanced release of mast cell mediators accompanied by accumulation of dysfunctional mast cells. Demonstration of familial clustering would be an important step towards defining the genetic contribution to the risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molderings, Gerhard J., Haenisch, Britta, Bogdanow, Manuela, Fimmers, Rolf, Nöthen, Markus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787002/ https://www.ncbi.nlm.nih.gov/pubmed/24098785 http://dx.doi.org/10.1371/journal.pone.0076241

Ejemplares similares

Pharmacological treatment options for mast cell activation disease
por: Molderings, Gerhard J., et al.
Publicado: (2016)

White matter abnormalities are also repeatedly present in patients with systemic mast cell activation syndrome
por: Haenisch, B, et al.
Publicado: (2018)

A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023)

Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
por: Vysniauskaite, Milda, et al.
Publicado: (2015)

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
por: Molderings, Gerhard J, et al.
Publicado: (2011)

Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA
por: Molderings, Gerhard J., et al.
Publicado: (2017)

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2022)

Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2023)

Mast cell activation symptoms are prevalent in Long-COVID
por: Weinstock, Leonard B., et al.
Publicado: (2021)

Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
por: Seidel, Holger, et al.
Publicado: (2021)

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020)

The German Version of the Manchester Triage System and Its Quality Criteria – First Assessment of Validity and Reliability
por: Gräff, Ingo, et al.
Publicado: (2014)

Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series
por: Weinstock, Leonard B., et al.
Publicado: (2022)

Prostaglandin D(2)-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study
por: Schäfer, Dirk, et al.
Publicado: (2014)

The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions
por: Yousefi, Omid Sascha, et al.
Publicado: (2013)

Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness
por: Molderings, G. J., et al.
Publicado: (2020)

Mast Cell Chymase and Kidney Disease
por: Vibhushan, Shamila, et al.
Publicado: (2020)

Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases
por: Folkerts, Jelle, et al.
Publicado: (2018)

Acupoint Activation: Response in Microcirculation and the Role of Mast Cells
por: Wang, Guangjun, et al.
Publicado: (2014)

Occurrence and Distribution of Canine Cutaneous Mast Cell Tumour Characteristics Among Predisposed Breeds
por: Śmiech, Anna, et al.
Publicado: (2019)

Case Report: Treatment of systemic mastocytosis with sunitinib
por: Molderings, Gerhard J., et al.
Publicado: (2017)

Editorial: Advances in mast cell physiology and mast cell-driven diseases
por: Blank, Ulrich, et al.
Publicado: (2023)

Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2021)

Mast cell activation syndrome
por: Ratner, Vicki
Publicado: (2015)

Mast Cell Activation Disorders
por: Giannetti, Arianna, et al.
Publicado: (2021)

Dental Pulp Inflammation Initiates the Occurrence of Mast Cells Expressing the α(1) and β(1) Subunits of Soluble Guanylyl Cyclase
por: Korkmaz, Yüksel, et al.
Publicado: (2023)

Mast Cell and Autoimmune Diseases
por: Xu, Yunzhi, et al.
Publicado: (2015)

Mast Cells in Neurodegenerative Disease
por: Jones, Michael K., et al.
Publicado: (2019)

Coeliac Disease and Mast Cells
por: Frossi, Barbara, et al.
Publicado: (2019)

Prognostic value of epigenetic markers for canine mast cell cancer
por: Syed, Shahzar, et al.
Publicado: (2023)

Human placental extract suppresses mast cell activation and induces mast cell apoptosis
por: Wu, Tongqian, et al.
Publicado: (2023)

Engineering, decoding and systems-level characterization of chimpanzee cytomegalovirus
por: Phan, Quang Vinh, et al.
Publicado: (2022)

Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
por: Bahri, Rajia, et al.
Publicado: (2018)

Correlation of mast cells in periodontal diseases
por: Lagdive, Sushma S., et al.
Publicado: (2013)

Are mast cells instrumental for fibrotic diseases?
por: Overed-Sayer, Catherine, et al.
Publicado: (2014)

Roles of Mast Cells in Cutaneous Diseases
por: Numata, Takafumi, et al.
Publicado: (2022)

Mast Cells in Human Health and Diseases
por: Traina, Giovanna
Publicado: (2023)

Editorial: Mast cells in allergic diseases
por: Kubala, Stephanie, et al.
Publicado: (2023)

THE MAST CELLS
Publicado: (1960)

Emerging Mechanisms of G(1)/S Cell Cycle Control by Human and Mouse Cytomegaloviruses
por: Bogdanow, Boris, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ktecob31o4vdq6l59ooa6bo1u